Characteristics of acquired reactive perforating collagenosis

Journal of Dermatology

Volumn 34, Issue 9, 2007, Pages 640-644

  Tsuboi, Hiromi ^a   Katsuoka, Kensei ^b  

^a NATIONAL HOSPITAL ORGANIZATION YOKOHAMA MEDICAL CENTER   (Japan)

^b KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Acquired reactive perforating collagenosis; Reticulin; Transforming growth factor (TGF)

Indexed keywords

COLLAGEN FIBER;

ACQQUIRED REACTIVE PERFORATING COLLAGENOSIS; ADOLESCENT; ADULT; AGED; ARTICLE; ATOPIC DERMATITIS; CLINICAL ARTICLE; CLINICAL FEATURE; COLLAGEN DISEASE; FEMALE; HUMAN; IMMUNOHISTOLOGY; MALE; SKIN DISEASE;

ADOLESCENT; ADULT; AGED; CARCINOMA, HEPATOCELLULAR; COLLAGEN; COLLAGEN DISEASES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PULMONARY FIBROSIS; RETICULIN; SKIN DISEASES; TRANSFORMING GROWTH FACTOR BETA;

EID: 34548175395     PISSN: 03852407     EISSN: 13468138     Source Type: Journal    
DOI: 10.1111/j.1346-8138.2007.00346.x     Document Type: Article

References (14)

1. Iyoda M, Hayashi F, Kuroki A et al. Acquired reactive perforating collagenosis in a nondiabetic hemodialysis patient: Successful treatment with allopurinol. Am J Kidney Dis 2003 42:E11 E13.
2. Faver IR, Daoud MS, Su WP. Acquired reactive perforating collagenosis: Report of six cases and review of the literature. J Am Acad Dermatol 1994 30:575 580.
3. McCormick LL, Zhang Y, Tootell E, Gilliam AC. Anti-TGF-beta treatment prevents skin and lung fibrosis inmurine sclerodermatous graft-versus-host disease: A model for human scleroderma. J Immunol 1999 15:5693 1600.
4. Bledsoe G, Shen B, Yao Y, Zhang JJ, Chao J. Reversal of renal fibrosis, inflammation and glomerular hypertrophy by kallikrein gene delivery. Hum Gene Ther 2006 17:545 555.
5. Tanabe K, Tsuboi H. A case of acquired reactive perforating collagenosis successfully treated with minocycline hydrochloride. Jpn J Clin Dermatol 2005 59:1306 1308 (in Japanese).
6. Tsuboi H, Arai H, Katsuoka K. Acquired reactive perforating collagenosis occurred after the deterioration of the control of diabetes mellitus. Rinsho Derma 2006 48:1797 1799 (in Japanese).
7. Tsuboi H, Mukuno A, Sato N, Katsuoka K, Yanase N. Acquired reactive perforating collagenosis in a patient with lung fibrosis. J Dermatol 2004 31:916 919.
8. Brinkmeier T, Herbst RA, Frosch PJ. Reactive perforating collagenosis associated with scabies in a diabetic. J Eur Acad Dermatol Venereol 2004 18:588 590.
9. Weiss SC, Moschella SL, Kwan T, Craven DE. Cutaneous mucormycosis secondary to acquired reactive perforating collagenosis. Cutis 2003 72:119 123.
10. Yanagihara M, Fujita T, Shirasaki A, Ishiguro K, Kawahara K, Ueda K. The pathogenesis of the transepidermal elimination of the collagen bundles in acquired reactive perforating collagenosis: A light and electron microscopical study. J Cutan Pathol 1996 23:398 403.
11. Morgan MB, Truitt CA, Taira J, Somach S, Pitha JV, Everett MA. Fibronectin and the extracellular matrix in the perforating disorders of the skin. Am J Dermatopatholol 1998 20:147 154.
12. Hoque SR, Ameen M, Holden CA. Acquired reactive perforating collagenosis: Four patients with a giant variant treated with allopurinol. Br J Dermatol 2006 154:759 762.
13. Kilic A, Gonul M, Cakmak SK, Gul U, Demiriz M. Acquired reactive perforating collagenosis as a presenting sign of hepatocellular carcinoma. Eur J Dermatol 2006 16:447.
14. Kawakami T, Soma Y, Mizoguchi M, Saito R. Immunohistochemical analysis of transforming growth factor-beta 3 expression in acquired reactive perforating collagenosis. Br J Dermatol 2001 144:197 199.